nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CA5B—cervicothoracic ganglion—systemic scleroderma	0.113	0.332	CbGeAlD
Acetazolamide—SLC22A6—Captopril—systemic scleroderma	0.082	0.59	CbGbCtD
Acetazolamide—AQP1—skeletal joint—systemic scleroderma	0.0593	0.174	CbGeAlD
Acetazolamide—SLC22A6—Methotrexate—systemic scleroderma	0.0259	0.186	CbGbCtD
Acetazolamide—AQP1—endothelium—systemic scleroderma	0.021	0.0614	CbGeAlD
Acetazolamide—AQP1—blood vessel—systemic scleroderma	0.0193	0.0566	CbGeAlD
Acetazolamide—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0172	0.124	CbGbCtD
Acetazolamide—CYP3A4—Prednisone—systemic scleroderma	0.0138	0.0992	CbGbCtD
Acetazolamide—AQP1—connective tissue—systemic scleroderma	0.00991	0.029	CbGeAlD
Acetazolamide—AQP1—smooth muscle tissue—systemic scleroderma	0.00906	0.0266	CbGeAlD
Acetazolamide—AQP1—skin of body—systemic scleroderma	0.00895	0.0262	CbGeAlD
Acetazolamide—CA3—connective tissue—systemic scleroderma	0.00727	0.0213	CbGeAlD
Acetazolamide—AQP1—digestive system—systemic scleroderma	0.00716	0.021	CbGeAlD
Acetazolamide—AQP1—tendon—systemic scleroderma	0.00681	0.02	CbGeAlD
Acetazolamide—AQP1—lung—systemic scleroderma	0.00598	0.0175	CbGeAlD
Acetazolamide—CA7—digestive system—systemic scleroderma	0.00572	0.0168	CbGeAlD
Acetazolamide—CA12—connective tissue—systemic scleroderma	0.00515	0.0151	CbGeAlD
Acetazolamide—CA9—digestive system—systemic scleroderma	0.00502	0.0147	CbGeAlD
Acetazolamide—CA3—tendon—systemic scleroderma	0.00499	0.0146	CbGeAlD
Acetazolamide—CA9—tendon—systemic scleroderma	0.00478	0.014	CbGeAlD
Acetazolamide—CA14—tendon—systemic scleroderma	0.00453	0.0133	CbGeAlD
Acetazolamide—CA3—lung—systemic scleroderma	0.00438	0.0128	CbGeAlD
Acetazolamide—CA12—digestive system—systemic scleroderma	0.00372	0.0109	CbGeAlD
Acetazolamide—CA5B—tendon—systemic scleroderma	0.00317	0.0093	CbGeAlD
Acetazolamide—CA12—lung—systemic scleroderma	0.0031	0.0091	CbGeAlD
Acetazolamide—CA1—digestive system—systemic scleroderma	0.00294	0.00863	CbGeAlD
Acetazolamide—CA5B—lung—systemic scleroderma	0.00278	0.00816	CbGeAlD
Acetazolamide—CA2—connective tissue—systemic scleroderma	0.00264	0.00774	CbGeAlD
Acetazolamide—CA1—lung—systemic scleroderma	0.00246	0.00721	CbGeAlD
Acetazolamide—CA2—smooth muscle tissue—systemic scleroderma	0.00242	0.00708	CbGeAlD
Acetazolamide—CA2—skin of body—systemic scleroderma	0.00239	0.00699	CbGeAlD
Acetazolamide—CA4—digestive system—systemic scleroderma	0.0023	0.00675	CbGeAlD
Acetazolamide—CA4—tendon—systemic scleroderma	0.00219	0.00642	CbGeAlD
Acetazolamide—Thirst—Mycophenolate mofetil—systemic scleroderma	0.00195	0.00375	CcSEcCtD
Acetazolamide—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00194	0.00373	CcSEcCtD
Acetazolamide—CA4—lung—systemic scleroderma	0.00192	0.00563	CbGeAlD
Acetazolamide—Flushing—Captopril—systemic scleroderma	0.00192	0.00369	CcSEcCtD
Acetazolamide—Shock—Pentoxifylline—systemic scleroderma	0.00191	0.00367	CcSEcCtD
Acetazolamide—CA2—digestive system—systemic scleroderma	0.00191	0.00559	CbGeAlD
Acetazolamide—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.00191	0.00367	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Azathioprine—systemic scleroderma	0.0019	0.00366	CcSEcCtD
Acetazolamide—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.0019	0.00366	CcSEcCtD
Acetazolamide—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.0019	0.00365	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00188	0.00362	CcSEcCtD
Acetazolamide—Agranulocytosis—Azathioprine—systemic scleroderma	0.00188	0.00361	CcSEcCtD
Acetazolamide—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00358	CcSEcCtD
Acetazolamide—CA2—tendon—systemic scleroderma	0.00182	0.00532	CbGeAlD
Acetazolamide—Haematuria—Leflunomide—systemic scleroderma	0.00181	0.00348	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Leflunomide—systemic scleroderma	0.0018	0.00346	CcSEcCtD
Acetazolamide—Agranulocytosis—Leflunomide—systemic scleroderma	0.00177	0.00341	CcSEcCtD
Acetazolamide—Dysgeusia—Captopril—systemic scleroderma	0.00176	0.00339	CcSEcCtD
Acetazolamide—Haematuria—Mycophenolic acid—systemic scleroderma	0.00173	0.00332	CcSEcCtD
Acetazolamide—Somnolence—Pentoxifylline—systemic scleroderma	0.00172	0.00332	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Mycophenolic acid—systemic scleroderma	0.00171	0.0033	CcSEcCtD
Acetazolamide—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00171	0.00328	CcSEcCtD
Acetazolamide—Erythema multiforme—Azathioprine—systemic scleroderma	0.00171	0.00328	CcSEcCtD
Acetazolamide—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00169	0.00325	CcSEcCtD
Acetazolamide—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00325	CcSEcCtD
Acetazolamide—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00169	0.00324	CcSEcCtD
Acetazolamide—Anaphylactic shock—Mometasone—systemic scleroderma	0.00167	0.00322	CcSEcCtD
Acetazolamide—Ill-defined disorder—Captopril—systemic scleroderma	0.00167	0.00322	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00167	0.00321	CcSEcCtD
Acetazolamide—Malaise—Captopril—systemic scleroderma	0.00162	0.00312	CcSEcCtD
Acetazolamide—Hypoaesthesia—Mycophenolic acid—systemic scleroderma	0.00162	0.00311	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00162	0.00311	CcSEcCtD
Acetazolamide—Erythema multiforme—Leflunomide—systemic scleroderma	0.00161	0.0031	CcSEcCtD
Acetazolamide—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.0016	0.00308	CcSEcCtD
Acetazolamide—CA2—lung—systemic scleroderma	0.00159	0.00467	CbGeAlD
Acetazolamide—Haematuria—Lisinopril—systemic scleroderma	0.00156	0.00299	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.00154	0.00297	CcSEcCtD
Acetazolamide—Urticaria—Pentoxifylline—systemic scleroderma	0.00154	0.00296	CcSEcCtD
Acetazolamide—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00153	0.00295	CcSEcCtD
Acetazolamide—Agranulocytosis—Lisinopril—systemic scleroderma	0.00152	0.00293	CcSEcCtD
Acetazolamide—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00152	0.00292	CcSEcCtD
Acetazolamide—Discomfort—Captopril—systemic scleroderma	0.00152	0.00291	CcSEcCtD
Acetazolamide—Paraesthesia—Mometasone—systemic scleroderma	0.0015	0.00289	CcSEcCtD
Acetazolamide—Confusional state—Captopril—systemic scleroderma	0.00148	0.00285	CcSEcCtD
Acetazolamide—Dyspepsia—Mometasone—systemic scleroderma	0.00147	0.00283	CcSEcCtD
Acetazolamide—Anaphylactic shock—Captopril—systemic scleroderma	0.00147	0.00283	CcSEcCtD
Acetazolamide—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00146	0.00281	CcSEcCtD
Acetazolamide—Decreased appetite—Mometasone—systemic scleroderma	0.00146	0.0028	CcSEcCtD
Acetazolamide—Dysgeusia—Leflunomide—systemic scleroderma	0.00145	0.0028	CcSEcCtD
Acetazolamide—Shock—Captopril—systemic scleroderma	0.00145	0.00278	CcSEcCtD
Acetazolamide—Fatigue—Mometasone—systemic scleroderma	0.00144	0.00278	CcSEcCtD
Acetazolamide—Thrombocytopenia—Captopril—systemic scleroderma	0.00144	0.00277	CcSEcCtD
Acetazolamide—Malaise—Azathioprine—systemic scleroderma	0.00142	0.00273	CcSEcCtD
Acetazolamide—Melaena—Methotrexate—systemic scleroderma	0.00142	0.00272	CcSEcCtD
Acetazolamide—Leukopenia—Azathioprine—systemic scleroderma	0.00141	0.00271	CcSEcCtD
Acetazolamide—Asthenia—Pentoxifylline—systemic scleroderma	0.00139	0.00268	CcSEcCtD
Acetazolamide—Erythema multiforme—Lisinopril—systemic scleroderma	0.00139	0.00267	CcSEcCtD
Acetazolamide—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00138	0.00265	CcSEcCtD
Acetazolamide—Tinnitus—Lisinopril—systemic scleroderma	0.00137	0.00263	CcSEcCtD
Acetazolamide—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00262	CcSEcCtD
Acetazolamide—Flushing—Lisinopril—systemic scleroderma	0.00136	0.00262	CcSEcCtD
Acetazolamide—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00136	0.00262	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00135	0.0026	CcSEcCtD
Acetazolamide—Malaise—Leflunomide—systemic scleroderma	0.00134	0.00258	CcSEcCtD
Acetazolamide—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00257	CcSEcCtD
Acetazolamide—Leukopenia—Leflunomide—systemic scleroderma	0.00133	0.00256	CcSEcCtD
Acetazolamide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00133	0.00255	CcSEcCtD
Acetazolamide—Body temperature increased—Mometasone—systemic scleroderma	0.00132	0.00255	CcSEcCtD
Acetazolamide—Discomfort—Azathioprine—systemic scleroderma	0.00132	0.00254	CcSEcCtD
Acetazolamide—Paraesthesia—Captopril—systemic scleroderma	0.00132	0.00254	CcSEcCtD
Acetazolamide—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00131	0.00253	CcSEcCtD
Acetazolamide—Urine output increased—Methotrexate—systemic scleroderma	0.00131	0.00252	CcSEcCtD
Acetazolamide—Somnolence—Captopril—systemic scleroderma	0.00131	0.00251	CcSEcCtD
Acetazolamide—Agitation—Mycophenolic acid—systemic scleroderma	0.0013	0.0025	CcSEcCtD
Acetazolamide—Dyspepsia—Captopril—systemic scleroderma	0.00129	0.00249	CcSEcCtD
Acetazolamide—Dizziness—Pentoxifylline—systemic scleroderma	0.00128	0.00247	CcSEcCtD
Acetazolamide—Decreased appetite—Captopril—systemic scleroderma	0.00128	0.00246	CcSEcCtD
Acetazolamide—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00246	CcSEcCtD
Acetazolamide—Malaise—Mycophenolic acid—systemic scleroderma	0.00128	0.00246	CcSEcCtD
Acetazolamide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00127	0.00244	CcSEcCtD
Acetazolamide—Fatigue—Captopril—systemic scleroderma	0.00127	0.00244	CcSEcCtD
Acetazolamide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00126	0.00242	CcSEcCtD
Acetazolamide—Dysgeusia—Lisinopril—systemic scleroderma	0.00125	0.0024	CcSEcCtD
Acetazolamide—Discomfort—Leflunomide—systemic scleroderma	0.00125	0.0024	CcSEcCtD
Acetazolamide—Vomiting—Pentoxifylline—systemic scleroderma	0.00123	0.00237	CcSEcCtD
Acetazolamide—CYP3A4—digestive system—systemic scleroderma	0.00123	0.00361	CbGeAlD
Acetazolamide—Convulsion—Mycophenolic acid—systemic scleroderma	0.00123	0.00236	CcSEcCtD
Acetazolamide—Headache—Pentoxifylline—systemic scleroderma	0.00122	0.00234	CcSEcCtD
Acetazolamide—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00121	0.00233	CcSEcCtD
Acetazolamide—Feeling abnormal—Captopril—systemic scleroderma	0.00121	0.00233	CcSEcCtD
Acetazolamide—Asthenia—Mometasone—systemic scleroderma	0.0012	0.00231	CcSEcCtD
Acetazolamide—Irritability—Prednisone—systemic scleroderma	0.0012	0.00231	CcSEcCtD
Acetazolamide—Photosensitivity—Methotrexate—systemic scleroderma	0.0012	0.0023	CcSEcCtD
Acetazolamide—Polyuria—Methotrexate—systemic scleroderma	0.0012	0.0023	CcSEcCtD
Acetazolamide—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0023	CcSEcCtD
Acetazolamide—Discomfort—Mycophenolic acid—systemic scleroderma	0.00119	0.00229	CcSEcCtD
Acetazolamide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00119	0.00228	CcSEcCtD
Acetazolamide—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00118	0.00228	CcSEcCtD
Acetazolamide—Hepatic failure—Methotrexate—systemic scleroderma	0.00117	0.00225	CcSEcCtD
Acetazolamide—Confusional state—Mycophenolic acid—systemic scleroderma	0.00117	0.00224	CcSEcCtD
Acetazolamide—Body temperature increased—Captopril—systemic scleroderma	0.00116	0.00224	CcSEcCtD
Acetazolamide—Nausea—Pentoxifylline—systemic scleroderma	0.00115	0.00222	CcSEcCtD
Acetazolamide—Malaise—Lisinopril—systemic scleroderma	0.00115	0.00221	CcSEcCtD
Acetazolamide—Diarrhoea—Mometasone—systemic scleroderma	0.00115	0.0022	CcSEcCtD
Acetazolamide—Hypokalaemia—Prednisone—systemic scleroderma	0.00115	0.0022	CcSEcCtD
Acetazolamide—Leukopenia—Lisinopril—systemic scleroderma	0.00114	0.0022	CcSEcCtD
Acetazolamide—Shock—Mycophenolic acid—systemic scleroderma	0.00114	0.00219	CcSEcCtD
Acetazolamide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00113	0.00218	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00111	0.00213	CcSEcCtD
Acetazolamide—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00211	CcSEcCtD
Acetazolamide—Paraesthesia—Leflunomide—systemic scleroderma	0.00109	0.00209	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00109	0.00209	CcSEcCtD
Acetazolamide—Discomfort—Lisinopril—systemic scleroderma	0.00107	0.00206	CcSEcCtD
Acetazolamide—Dyspepsia—Leflunomide—systemic scleroderma	0.00107	0.00205	CcSEcCtD
Acetazolamide—Vomiting—Mometasone—systemic scleroderma	0.00106	0.00205	CcSEcCtD
Acetazolamide—Feeling abnormal—Azathioprine—systemic scleroderma	0.00106	0.00203	CcSEcCtD
Acetazolamide—Asthenia—Captopril—systemic scleroderma	0.00106	0.00203	CcSEcCtD
Acetazolamide—Decreased appetite—Leflunomide—systemic scleroderma	0.00105	0.00203	CcSEcCtD
Acetazolamide—Confusional state—Lisinopril—systemic scleroderma	0.00105	0.00202	CcSEcCtD
Acetazolamide—Headache—Mometasone—systemic scleroderma	0.00105	0.00202	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00105	0.00201	CcSEcCtD
Acetazolamide—Fatigue—Leflunomide—systemic scleroderma	0.00104	0.00201	CcSEcCtD
Acetazolamide—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00104	0.002	CcSEcCtD
Acetazolamide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00104	0.002	CcSEcCtD
Acetazolamide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00199	CcSEcCtD
Acetazolamide—Somnolence—Mycophenolic acid—systemic scleroderma	0.00103	0.00198	CcSEcCtD
Acetazolamide—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00198	CcSEcCtD
Acetazolamide—Shock—Lisinopril—systemic scleroderma	0.00102	0.00197	CcSEcCtD
Acetazolamide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00102	0.00196	CcSEcCtD
Acetazolamide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00102	0.00196	CcSEcCtD
Acetazolamide—Body temperature increased—Azathioprine—systemic scleroderma	0.00101	0.00195	CcSEcCtD
Acetazolamide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00194	CcSEcCtD
Acetazolamide—Diarrhoea—Captopril—systemic scleroderma	0.00101	0.00193	CcSEcCtD
Acetazolamide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00101	0.00193	CcSEcCtD
Acetazolamide—Irritability—Methotrexate—systemic scleroderma	0.001	0.00193	CcSEcCtD
Acetazolamide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.001	0.00192	CcSEcCtD
Acetazolamide—Feeling abnormal—Leflunomide—systemic scleroderma	0.000999	0.00192	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000998	0.00192	CcSEcCtD
Acetazolamide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000997	0.00192	CcSEcCtD
Acetazolamide—Nausea—Mometasone—systemic scleroderma	0.000994	0.00191	CcSEcCtD
Acetazolamide—Ataxia—Methotrexate—systemic scleroderma	0.000989	0.0019	CcSEcCtD
Acetazolamide—Dizziness—Captopril—systemic scleroderma	0.000972	0.00187	CcSEcCtD
Acetazolamide—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000969	0.00186	CcSEcCtD
Acetazolamide—Urticaria—Leflunomide—systemic scleroderma	0.000963	0.00185	CcSEcCtD
Acetazolamide—Body temperature increased—Leflunomide—systemic scleroderma	0.000958	0.00184	CcSEcCtD
Acetazolamide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000953	0.00183	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000947	0.00182	CcSEcCtD
Acetazolamide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00094	0.00181	CcSEcCtD
Acetazolamide—Paraesthesia—Lisinopril—systemic scleroderma	0.000935	0.0018	CcSEcCtD
Acetazolamide—Vomiting—Captopril—systemic scleroderma	0.000935	0.0018	CcSEcCtD
Acetazolamide—Somnolence—Lisinopril—systemic scleroderma	0.000926	0.00178	CcSEcCtD
Acetazolamide—Headache—Captopril—systemic scleroderma	0.000921	0.00177	CcSEcCtD
Acetazolamide—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00092	0.00177	CcSEcCtD
Acetazolamide—Dyspepsia—Lisinopril—systemic scleroderma	0.000917	0.00176	CcSEcCtD
Acetazolamide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000914	0.00176	CcSEcCtD
Acetazolamide—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000912	0.00175	CcSEcCtD
Acetazolamide—Decreased appetite—Lisinopril—systemic scleroderma	0.000905	0.00174	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000899	0.00173	CcSEcCtD
Acetazolamide—Fatigue—Lisinopril—systemic scleroderma	0.000898	0.00173	CcSEcCtD
Acetazolamide—Shock—Mycophenolate mofetil—systemic scleroderma	0.000898	0.00173	CcSEcCtD
Acetazolamide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00172	CcSEcCtD
Acetazolamide—Diarrhoea—Azathioprine—systemic scleroderma	0.000878	0.00169	CcSEcCtD
Acetazolamide—Nausea—Captopril—systemic scleroderma	0.000873	0.00168	CcSEcCtD
Acetazolamide—Asthenia—Leflunomide—systemic scleroderma	0.00087	0.00167	CcSEcCtD
Acetazolamide—Feeling abnormal—Lisinopril—systemic scleroderma	0.000858	0.00165	CcSEcCtD
Acetazolamide—Dizziness—Azathioprine—systemic scleroderma	0.000849	0.00163	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00083	0.0016	CcSEcCtD
Acetazolamide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00083	0.0016	CcSEcCtD
Acetazolamide—Diarrhoea—Leflunomide—systemic scleroderma	0.000829	0.00159	CcSEcCtD
Acetazolamide—Urticaria—Lisinopril—systemic scleroderma	0.000827	0.00159	CcSEcCtD
Acetazolamide—Body temperature increased—Lisinopril—systemic scleroderma	0.000823	0.00158	CcSEcCtD
Acetazolamide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000819	0.00158	CcSEcCtD
Acetazolamide—Vomiting—Azathioprine—systemic scleroderma	0.000816	0.00157	CcSEcCtD
Acetazolamide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000811	0.00156	CcSEcCtD
Acetazolamide—Drowsiness—Methotrexate—systemic scleroderma	0.00081	0.00156	CcSEcCtD
Acetazolamide—Flushing—Prednisone—systemic scleroderma	0.000808	0.00155	CcSEcCtD
Acetazolamide—Headache—Azathioprine—systemic scleroderma	0.000804	0.00155	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000804	0.00155	CcSEcCtD
Acetazolamide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000803	0.00154	CcSEcCtD
Acetazolamide—Dizziness—Leflunomide—systemic scleroderma	0.000801	0.00154	CcSEcCtD
Acetazolamide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000793	0.00153	CcSEcCtD
Acetazolamide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000791	0.00152	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000788	0.00151	CcSEcCtD
Acetazolamide—Haematuria—Methotrexate—systemic scleroderma	0.000773	0.00149	CcSEcCtD
Acetazolamide—Vomiting—Leflunomide—systemic scleroderma	0.000771	0.00148	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000766	0.00147	CcSEcCtD
Acetazolamide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000765	0.00147	CcSEcCtD
Acetazolamide—Nausea—Azathioprine—systemic scleroderma	0.000762	0.00147	CcSEcCtD
Acetazolamide—Headache—Leflunomide—systemic scleroderma	0.000759	0.00146	CcSEcCtD
Acetazolamide—Agranulocytosis—Methotrexate—systemic scleroderma	0.000756	0.00145	CcSEcCtD
Acetazolamide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000752	0.00145	CcSEcCtD
Acetazolamide—Asthenia—Lisinopril—systemic scleroderma	0.000747	0.00144	CcSEcCtD
Acetazolamide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000735	0.00141	CcSEcCtD
Acetazolamide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000725	0.00139	CcSEcCtD
Acetazolamide—Headache—Mycophenolic acid—systemic scleroderma	0.000724	0.00139	CcSEcCtD
Acetazolamide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000721	0.00139	CcSEcCtD
Acetazolamide—Nausea—Leflunomide—systemic scleroderma	0.00072	0.00138	CcSEcCtD
Acetazolamide—Diarrhoea—Lisinopril—systemic scleroderma	0.000713	0.00137	CcSEcCtD
Acetazolamide—Ill-defined disorder—Prednisone—systemic scleroderma	0.000703	0.00135	CcSEcCtD
Acetazolamide—Agitation—Prednisone—systemic scleroderma	0.000696	0.00134	CcSEcCtD
Acetazolamide—Dizziness—Lisinopril—systemic scleroderma	0.000689	0.00132	CcSEcCtD
Acetazolamide—Erythema multiforme—Methotrexate—systemic scleroderma	0.000688	0.00132	CcSEcCtD
Acetazolamide—Nausea—Mycophenolic acid—systemic scleroderma	0.000687	0.00132	CcSEcCtD
Acetazolamide—Malaise—Prednisone—systemic scleroderma	0.000683	0.00131	CcSEcCtD
Acetazolamide—Tinnitus—Methotrexate—systemic scleroderma	0.000678	0.0013	CcSEcCtD
Acetazolamide—Vomiting—Lisinopril—systemic scleroderma	0.000662	0.00127	CcSEcCtD
Acetazolamide—Convulsion—Prednisone—systemic scleroderma	0.000657	0.00126	CcSEcCtD
Acetazolamide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000655	0.00126	CcSEcCtD
Acetazolamide—Headache—Lisinopril—systemic scleroderma	0.000652	0.00125	CcSEcCtD
Acetazolamide—Discomfort—Prednisone—systemic scleroderma	0.000637	0.00123	CcSEcCtD
Acetazolamide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000624	0.0012	CcSEcCtD
Acetazolamide—Dysgeusia—Methotrexate—systemic scleroderma	0.00062	0.00119	CcSEcCtD
Acetazolamide—Nausea—Lisinopril—systemic scleroderma	0.000619	0.00119	CcSEcCtD
Acetazolamide—Anaphylactic shock—Prednisone—systemic scleroderma	0.000618	0.00119	CcSEcCtD
Acetazolamide—Shock—Prednisone—systemic scleroderma	0.000609	0.00117	CcSEcCtD
Acetazolamide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000603	0.00116	CcSEcCtD
Acetazolamide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000588	0.00113	CcSEcCtD
Acetazolamide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00058	0.00112	CcSEcCtD
Acetazolamide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000572	0.0011	CcSEcCtD
Acetazolamide—Malaise—Methotrexate—systemic scleroderma	0.000571	0.0011	CcSEcCtD
Acetazolamide—Leukopenia—Methotrexate—systemic scleroderma	0.000567	0.00109	CcSEcCtD
Acetazolamide—Paraesthesia—Prednisone—systemic scleroderma	0.000555	0.00107	CcSEcCtD
Acetazolamide—Convulsion—Methotrexate—systemic scleroderma	0.000549	0.00106	CcSEcCtD
Acetazolamide—Dyspepsia—Prednisone—systemic scleroderma	0.000544	0.00105	CcSEcCtD
Acetazolamide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000542	0.00104	CcSEcCtD
Acetazolamide—Decreased appetite—Prednisone—systemic scleroderma	0.000538	0.00103	CcSEcCtD
Acetazolamide—Fatigue—Prednisone—systemic scleroderma	0.000533	0.00103	CcSEcCtD
Acetazolamide—Discomfort—Methotrexate—systemic scleroderma	0.000533	0.00102	CcSEcCtD
Acetazolamide—Confusional state—Methotrexate—systemic scleroderma	0.000521	0.001	CcSEcCtD
Acetazolamide—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000517	0.000994	CcSEcCtD
Acetazolamide—Feeling abnormal—Prednisone—systemic scleroderma	0.00051	0.00098	CcSEcCtD
Acetazolamide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000506	0.000973	CcSEcCtD
Acetazolamide—Urticaria—Prednisone—systemic scleroderma	0.000491	0.000945	CcSEcCtD
Acetazolamide—Body temperature increased—Prednisone—systemic scleroderma	0.000489	0.00094	CcSEcCtD
Acetazolamide—Paraesthesia—Methotrexate—systemic scleroderma	0.000464	0.000893	CcSEcCtD
Acetazolamide—Somnolence—Methotrexate—systemic scleroderma	0.00046	0.000884	CcSEcCtD
Acetazolamide—Dyspepsia—Methotrexate—systemic scleroderma	0.000455	0.000875	CcSEcCtD
Acetazolamide—Decreased appetite—Methotrexate—systemic scleroderma	0.000449	0.000864	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000446	0.000858	CcSEcCtD
Acetazolamide—Fatigue—Methotrexate—systemic scleroderma	0.000446	0.000857	CcSEcCtD
Acetazolamide—Asthenia—Prednisone—systemic scleroderma	0.000444	0.000853	CcSEcCtD
Acetazolamide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000426	0.000819	CcSEcCtD
Acetazolamide—Diarrhoea—Prednisone—systemic scleroderma	0.000423	0.000814	CcSEcCtD
Acetazolamide—Urticaria—Methotrexate—systemic scleroderma	0.000411	0.00079	CcSEcCtD
Acetazolamide—Dizziness—Prednisone—systemic scleroderma	0.000409	0.000787	CcSEcCtD
Acetazolamide—Body temperature increased—Methotrexate—systemic scleroderma	0.000409	0.000786	CcSEcCtD
Acetazolamide—Vomiting—Prednisone—systemic scleroderma	0.000393	0.000756	CcSEcCtD
Acetazolamide—Headache—Prednisone—systemic scleroderma	0.000387	0.000745	CcSEcCtD
Acetazolamide—Asthenia—Methotrexate—systemic scleroderma	0.000371	0.000713	CcSEcCtD
Acetazolamide—Nausea—Prednisone—systemic scleroderma	0.000367	0.000707	CcSEcCtD
Acetazolamide—Diarrhoea—Methotrexate—systemic scleroderma	0.000354	0.00068	CcSEcCtD
Acetazolamide—Dizziness—Methotrexate—systemic scleroderma	0.000342	0.000657	CcSEcCtD
Acetazolamide—Vomiting—Methotrexate—systemic scleroderma	0.000329	0.000632	CcSEcCtD
Acetazolamide—Headache—Methotrexate—systemic scleroderma	0.000324	0.000623	CcSEcCtD
Acetazolamide—Nausea—Methotrexate—systemic scleroderma	0.000307	0.00059	CcSEcCtD
